Eribulin Tillomed

Medicinal product

(Invented) name

Eribulin Tillomed

Active substance (s)

Eribulinas

Strength

0,44 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XX41, Eribulin

Marketing authorisation holder

Tillomed Malta Limited, Malta

Date of authorisation

2026-08-11

Date of renewal

Documents

6120_Eribulin Tillomed.docx

6120_pakuotes lapelis_2026-08-11.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/7930/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Eribulinas	0,44 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121954	108062	1108062	flakonas	2 ml N1		Receptinis	LT/1/26/6120/001	Netiekiama	-	-	No	-	-
121955	108063	1108063	flakonas	2 ml N6		Receptinis	LT/1/26/6120/002	Netiekiama	-	-	No	-	-
121956	108064	1108064	flakonas	3 ml N1		Receptinis	LT/1/26/6120/003	Netiekiama	-	-	No	-	-
121957	108065	1108065	flakonas	3 ml N6		Receptinis	LT/1/26/6120/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-08-11	Registruotas